Clinical Trial Update: Nintedanib in Patients With Bronchiolitis Obliterans Syndrome Following Hematopoietic Stem Cell Transplantation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating nintedanib for bronchiolitis obliterans syndrome and bronchiolitis obliterans after hematopoietic stem cell transplantation is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiolitis Obliterans
• Bronchiolitis Obliterans Syndrome

Drugs mentioned

• OFEV (Nintedanib)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Bronchiolitis Obliterans Syndrome (BOS), Bronchiolitis Obliterans (BO) | Phase 2 | Status: RECRUITING